Ir para o conteúdo
VuFind
  • 我的帳戶
  • 退出
  • 登錄
  • 語言
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português (Brasil)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
高級檢索
  • Immunogenetic characterization...
  • Previsualização
  • 引用
  • 推薦此
  • 打印
  • 導出紀錄
    • 導出到 RefWorks
    • 導出到 EndNoteWeb
    • 導出到 EndNote
    • 導出到 BibTeX
    • 導出到 RIS
  • 加到收藏夾
載入...

Código QR

Immunogenetic characterization of clonal plasma cells in systemic light-chain amyloidosis

Na minha lista:
書目詳細資料
發表在:Leukemia
Main Authors: Cuenca, Isabel, Alameda, Daniel, Sanchez-Vega, Beatriz, Gomez-Sanchez, David, Alignani, Diego, Lasa, Marta, Onecha, Esther, Lecumberri, Ramon, Prosper, Felipe, Ocio, Enrique M., González, Maria Esther, García de Coca, Alfonso, De La Rubia, Javier, Gironella, Mercedes, Palomera, Luis, Oriol, Albert, Casanova, Maria, Cabañas, Valentin, Taboada, Francisco, Pérez-Montaña, Albert, De Arriba, Felipe, Puig, Noemi, Carreño-Tarragona, Gonzalo, Barrio, Santiago, Enrique de la Puerta, Jose, Ramirez-Payer, Angel, Krsnik, Isabel, Bargay, Juan Jose, Lahuerta, Juan Jose, Mateos, Maria-Victoria, San-Miguel, Jesus F., Paiva, Bruno, Martinez-Lopez, Joaquin
格式: Artigo
語言:Inglês
出版: Nature Publishing Group UK 2020
主題:
Letter
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7787969/
https://ncbi.nlm.nih.gov/pubmed/32203144
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41375-020-0800-6
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!
  • 持有資料
  • 實物特徵
  • 您的評論
  • Previsualização
  • 相似書籍
  • 職員瀏覽

相似書籍

  • Bendamustine, bortezomib and prednisone for the treatment of patients with newly diagnosed multiple myeloma: results of a prospective phase 2 Spanish/PETHEMA trial
    由: Mateos, María-Victoria, et al.
    出版: (2015)
  • Bortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplant in multiple myeloma
    由: Rosiñol, Laura, et al.
    出版: (2019)
  • High‐risk cytogenetic abnormalities in multiple myeloma: PETHEMA‐GEM experience
    由: Veronica González‐Calle, et al.
    出版: (2024-12-01)
  • Predicting long-term disease control in transplant-ineligible patients with multiple myeloma: impact of an MGUS-like signature
    由: Rodríguez-Otero, Paula, et al.
    出版: (2019)
  • Zoledronic acid as compared with observation in multiple myeloma patients at biochemical relapse: results of the randomized AZABACHE Spanish trial
    由: García-Sanz, Ramón, et al.
    出版: (2015)

檢索選項

  • 檢索歷史
  • 高級檢索

查找更多

  • 瀏覽目錄
  • 按字母順序瀏覽
  • Explore Channels
  • 課程儲備
  • 新項目

需要幫助?

  • 檢索技巧
  • 咨詢台
  • 常見問題
載入...